C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
167/114, 530/15.
C07K 14/805 (2006.01) A61L 2/00 (2006.01) A61K 38/00 (2006.01)
Patent
CA 1306583
ABSTRACT OF THE DISCLOSURE The present specification describes a process by which a blood substitute (hereinafter referred to as "HemoSafe") is derived from uniformly stabilized monomers and polymers of deoxyhemoglobin in its tight (T) conformation, with oxygen affinity similar to that of human blood. Two classes of HemoSafe are derived respectively from animal-hemoglobin and human- hemoglobin. HemoSafe (animal) differs from HemoSafe (human) in that it is free of polymers in order to reduce potential immunogenicity if used in man. Both types of HemoSafe may be derived in the following manner. The stabilized deoxyhemoglobins are converted to their carbonmonoxy derivatives (CO-HemoSafe) which are then stable under pasteurization conditions to render them viral disease transmission-free. CO-HemoSafes are stable for 2 months at 56°C in either the solution or the freeze-dried state. For transfusion CO-HemoSafes are easily oxygenated under sterile conditions by photoconversion yielding oxy-HemoSafe. In addition a transfusable met-hemoglobin derivative for treatment of cyanide poisoning, is derived by converting oxy-HemoSafe to met-HemoSafe.
565563
As Represented By The Ministe R. Of National Defence Her Majesty The Queen In Right Of Canada
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Pasteurizable, freeze-driable hemoglobin-based blood substitute does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pasteurizable, freeze-driable hemoglobin-based blood substitute, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pasteurizable, freeze-driable hemoglobin-based blood substitute will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1236694